{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:07:47Z","timestamp":1785596867641,"version":"3.56.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejmech.2020.112996","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T02:14:12Z","timestamp":1604628852000},"page":"112996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"212","author":[{"given":"Satyaveni","family":"Malasala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-6107","authenticated-orcid":false,"given":"Md Naiyaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"Akunuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjulika","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-8694","authenticated-orcid":false,"given":"Y.V.","family":"Madhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-6074","authenticated-orcid":false,"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112996_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/03009734.2014.901444","article-title":"Emergence and spread of antibiotic resistance: setting a parameter space","volume":"119","author":"Mart\u00ednez","year":"2014","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2020.112996_bib2","article-title":"Global disease burden due to antibiotic resistanceestate of the evidence","volume":"6","author":"Woolhouse","year":"2016","journal-title":"J.\u00a0Glob. Health"},{"key":"10.1016\/j.ejmech.2020.112996_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/femsre\/fuw005","article-title":"Escherichia coli: an old friend with new tidings","volume":"40","author":"Vila","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112996_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1586\/eri.12.110","article-title":"Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment","volume":"10","author":"Pitout","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2020.112996_bib5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1021\/acs.accounts.8b00643","article-title":"Differential drivers of antimicrobial resistance across the world","volume":"52","author":"Vikesland","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112996_bib6","series-title":"Tackling drug-resistant infections globally: final report and recommendations, The review on antimicrobial resistance","author":"O\u2019Neill","year":"2016"},{"key":"10.1016\/j.ejmech.2020.112996_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-018-0278-9","article-title":"Species-specific activity of antibacterial drug combinations","volume":"559","author":"Brochado","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112996_bib8","first-page":"1804838","article-title":"Antibacterial carbon-based nanomaterials","author":"Xin","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2020.112996_bib9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1039\/C7MD00209B","article-title":"Synthesis and molecular docking studies of xanthone attached amino acids as potential antimicrobial and anti-inflammatory agents","volume":"8","author":"Chen","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.112996_bib10","doi-asserted-by":"crossref","first-page":"103113","DOI":"10.1016\/j.bioorg.2019.103133","article-title":"Chalcone derivatives and their antibacterial activities: current development","volume":"91","author":"Xu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib11a","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bioorg.2018.08.001","article-title":"Aryl fluorosulfate analogues as potent antimicrobial agents: SAR, cytotoxicity and docking studies","volume":"81","author":"Ravindar","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib11b","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2020.112996_bib11c","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S2213-2600(18)30057-2","article-title":"The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era","volume":"6","author":"Floyd","year":"2018","journal-title":"Lancet Res Med"},{"key":"10.1016\/j.ejmech.2020.112996_bib11d","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/0974-777X.81691","article-title":"Tuberculosis: current situation, challenges and overview of its control programs in India","volume":"3","author":"Sandhu","year":"2011","journal-title":"J.\u00a0Global Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112996_bib13a","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1016\/j.bmcl.2013.07.006","article-title":"A\u00a0medicinal chemists guide to the unique difficulties of lead optimization for tuberculosis","volume":"23","author":"Dartoisa","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112996_bib13b","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bmcl.2016.11.084","article-title":"Recent advancements in the development of anti-tuberculosis drugs","volume":"27","author":"Chetty","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112996_bib13c","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejmech.2019.01.002","article-title":"Synthesis and evaluation of a-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis","volume":"164","author":"Makane","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(06)68853-3","article-title":"Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat","volume":"368","author":"Grundmann","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2020.112996_bib15a","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmech.2018.09.042","article-title":"Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones","volume":"160","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib15b","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejmech.2017.12.017","article-title":"1,3,5-triazaspiro [5.5] undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity","volume":"144","author":"Yang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_sref13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0014-827X(00)00100-2","article-title":"Quinazoline derivatives with antitubercular activity","volume":"55","author":"Kunes","year":"2000","journal-title":"Il Farmaco"},{"key":"10.1016\/j.ejmech.2020.112996_bib16b","first-page":"1056","article-title":"Design and synthesis of novel 2-Trichloromethyl-4-substituted quinazoline derivatives as anti-tubercular agents","volume":"2","author":"Srivastav","year":"2013","journal-title":"Chem Sci Trans"},{"key":"10.1016\/j.ejmech.2020.112996_bib16c","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejmech.2019.04.067","article-title":"Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis","volume":"175","author":"Gatadi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib16d","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00044-011-9632-2","article-title":"Synthesis, characterization, and antimicrobial studies of novel 1,3,4-thiadiazolium-5-thiolates","volume":"21","author":"Asundaria","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112996_sref17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/ml500497s","article-title":"Synthesis and evaluation of quinazolines as inhibitors of the bacterial cell division protein FtsZ","volume":"63","author":"Nepomuceno","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112996_bib17b","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/jm9903500","article-title":"Structure\u2212activity relationships of novel 2-substituted quinazoline antibacterial agents","volume":"42","author":"Kung","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejmech.2014.04.072","article-title":"New horizons in anticonvulsant therapy","volume":"80","author":"Ugalea","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib19a","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/jm5000408","article-title":"Antileishmanial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines","volume":"57","author":"Horn","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib19b","first-page":"87","article-title":"Antibacterial, antifungal and cytotoxic evaluation of some new quinazolinone derivatives","volume":"7","author":"Hassanzadeh","year":"2012","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.ejmech.2020.112996_bib19c","first-page":"1475","article-title":"Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline\u2013triazine derivatives","author":"Modh","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_sref20a","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1039\/C4MD00392F","article-title":"Synthesis, 3D pharmacophore, QSAR and docking studies of novel quinazoline derivatives with nitric oxide release moiety as preferential COX-2 inhibitors","volume":"6","author":"Farag","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.112996_bib20b","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.ejmech.2010.07.067","article-title":"Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives","volume":"45","author":"Alafeefya","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib20c","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/jm901379s","article-title":"Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists","volume":"53","author":"Smits","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_sref21a","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/jm950645n","article-title":"Quinazoline antifolates thymidylate synthase inhibitors: Lipophilic analogues with modification to the C2-methyl substituent","volume":"39","author":"Hennequin","year":"1996","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib21b","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1021\/acs.jmedchem.7b00441","article-title":"4-Anilino-2-pyridylquinazolines and -pyrimidines as highly potent and nontoxic inhibitors of breast cancer resistance protein (ABCG2)","volume":"60","author":"Krapf","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib21c","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cbdd.13405","article-title":"Design, synthesis, and biological evaluation of quinazoline derivatives as dual HDAC1 and HDAC6 inhibitors for the treatment of cancer","volume":"93","author":"Chen","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112996_bib22","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/acs.jmedchem.6b00372","article-title":"Structureeactivity relationship for the 4 (3 H)-Quinazolinone antibacterials","volume":"59","author":"Bouley","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib23a","first-page":"569e579","article-title":"Synthesis and evaluation of new 4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant Staphylococcus aureus","volume":"83","author":"Gatadi","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib23b","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bioorg.2018.08.012","article-title":"Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)","volume":"81","author":"Gatadi","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib24","doi-asserted-by":"crossref","first-page":"128493","DOI":"10.1016\/j.molstruc.2020.128493","article-title":"Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents","volume":"1218","author":"Malasala","year":"2020","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2020.112996_bib25a","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.01.052","article-title":"Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents","volume":"111","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib25b","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ejmech.2005.05.005","article-title":"Synthesis, antibacterial, antifungal activity and interaction of CT-DNA with a new benzimidazole derived Cu(II) complex","volume":"40","author":"Arjmand","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib25c","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.01.052","article-title":"Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents","volume":"111","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib26a","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1016\/j.ejmech.2009.04.037","article-title":"Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives","volume":"44","author":"Ansari","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib26b","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.2174\/1568026616666160506145943","article-title":"Heterocyclic naphthalimides as new skeleton structure of compounds with increasingly expanding relational medicinal applications","volume":"16","author":"Gong","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib26c","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.bmcl.2016.04.070","article-title":"Discovery of novel berberine imidazoles as safe antimicrobial agents by down regulating ROS generation","volume":"26","author":"Wen","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112996_bib26d","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2014.08.063","article-title":"Novel hybrids of metronidazole and quinolones: synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin","volume":"86","author":"Cui","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib26e","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1039\/C5MD00186B","article-title":"Design, synthesis, and antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators","volume":"6","author":"Zhang","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.112996_bib27","doi-asserted-by":"crossref","first-page":"111850","DOI":"10.1016\/j.ejmech.2019.111850","article-title":"Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria","volume":"186","author":"Dokla","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib28","doi-asserted-by":"crossref","first-page":"112010","DOI":"10.1016\/j.ejmech.2019.112010","article-title":"Novel benzimidazole-acrylonitrile hybrids and their derivatives: design, synthesis and antimycobacterial activity","volume":"188","author":"Mustafa","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib29","first-page":"796","article-title":"Role of individual drugs in the chemotherapy of tuberculosis Role of individual drugs in the chemotherapy of tuberculosis","volume":"4","author":"Mitchison","year":"2000","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.ejmech.2020.112996_bib30a","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.tetlet.2014.02.065","article-title":"Synthesis of quinazolinones from anthranilamides and aldehydes via metal-free aerobic oxidation in DMSO","volume":"55","author":"Kim","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2020.112996_bib30b","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejmech.2018.10.026","article-title":"Synthesis and biological evaluation of quinazoline derivatives- A SAR study of novel inhibitors of ABCG2","volume":"161","author":"Krapf","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112996_bib31","series-title":"CLSI Document M07-A9","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard","author":"Wayne","year":"2012"},{"key":"10.1016\/j.ejmech.2020.112996_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/510431","article-title":"New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria","volume":"44","author":"Jorgensen","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112996_bib33a","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1038\/s41598-017-11575-5","article-title":"Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity","volume":"7","author":"Pandey","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112996_bib33b","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2020.112996_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.112996_bib35","first-page":"38","article-title":"In-vitro cytotoxicity activity of Solanum nigrum extract against Hela cell line and Vero cell line","volume":"1","author":"Patel","year":"2009","journal-title":"Int. J. Pharm. Pharmaceut. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420309685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420309685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:23:55Z","timestamp":1759328635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420309685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":59,"alternative-id":["S0223523420309685"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112996","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112996"}}